Life Sciences Update - November 2017

Life Sciences Update - November 2017

Welcome to our Life Science Issue, a monthly update from the Life Sciences team at S&B, containing news about recent and topical developments.

Contact our experts for further advice

View profile for Charlotte TillettCharlotte Tillett, View profile for Gustaf DuhsGustaf Duhs
  1. European Medicines Agency will relocate to Amsterdam

    On 20 November 2017, in a hotly contested vote, the General Affairs Council decided that the EMA, which has been based in London since its creation in 1995, will relocate to Amsterdam on 30 March 2019.  Out of the 18 other candidate cities, other close... Read more
  2. Life Sciences: In other Brexit news...

    With March 2019 fast approaching, there have been more Brexit-related developments in the Life Sciences sector which we wanted to highlight to you. UK Parliament’s briefing paper on Brexit and medicines regulation The briefing paper, which was... Read more
  3. Budget analysis: What is in it for Life Sciences?

    In late October the UK Chancellor announced that there would be £17 million of new life sciences funding to help create benefits for the NHS and patients. Looking at the Budget which was published on 22 November 2017, there are some interesting... Read more
  4. High Court considers claim interpretation and novelty following Supreme Court's recent judgment on equivalents

    In July 2017 the UK Supreme Court clarified the circumstances in which the monopoly granted by a patent could be widened beyond the normal interpretation of the claim to cover variants which have no material effect on the way the invention works. This... Read more
  5. Dosage regimes - "obvious to try" rides again

    In a decision which is likely to make it more difficult to patent dosage regimes in future, the Court of Appeal has overturned the High Court’s finding that a patent for a dosage regime for CIALIS was valid.  CIALIS is used, among other things,... Read more
  6. Stevens & Bolton LLP ranked in The Legal 500 directory

    We are delighted to have been ranked for Pharmaceuticals and Biotechnology in the 2017 edition of The Legal 500 directory, the only firm without a London presence. The firm also gained rankings in over 20 other areas.

Search our site